Ameriprise
PMN icon

Ameriprise’s ProMIS Neurosciences PMN Stock Holding History

Ameriprise’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
+185,700
New +$2.02M ﹤0.01% 2975

Other funds holding PMN

JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ameriprise's PMN Position: Q2 2026 in Review

Ameriprise opened a new position in ProMIS Neurosciences (PMN) in Q2 2026: 185,700 shares worth $2.44M. The stake represents ﹤0.01% of the portfolio and ranks #2975 among its holdings.

22 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Ameriprise held 185,700 shares of ProMIS Neurosciences worth $2.44M as of Q2 2026.
  • ProMIS Neurosciences was a new Ameriprise position in Q2 2026.
  • ProMIS Neurosciences made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2975 holding.
  • 22 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.